GlassScriptPhysician profile
Laura Rivera Cout
NPI 1740366640
$1,304.85
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $808 · 2020: $299 · 2021: $146 · 2022: $52.07.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Welch Allyn | $355.82 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $200.02 | 2019-2022 | |
| Lilly USA, LLC | $117.09 | 2019-2021 | |
| Amarin Pharma, INC. | $111.20 | 2019-2020 | |
| Genentech USA, INC. | $90.77 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $85.37 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $84.33 | 2019-2021 | |
| Advanced Oxygen Therapy INC. | $71.42 | 2021 | |
| Novo Nordisk INC | $56.42 | 2020-2022 | |
| Philips North America LLC | $30.69 | 2019-2020 | |
| Daiichi Sankyo INC. | $29.94 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $24.98 | 2019 | |
| Glaxosmithkline, LLC. | $18.06 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $14.83 | 2020 | |
| Amgen INC. | $13.91 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Rivera Cout listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.